Optimal Cancer Care Alliance (@OCCA_Cancer) header
Optimal Cancer Care Alliance (@OCCA_Cancer) profile picture

Optimal dosage. Best outcome. (Formerly The Value in Cancer Care Consortium)

Ann Arbor, MI
Joined November 2019
Photo by Optimal Cancer Care Alliance (@OCCA_Cancer)Photo by Optimal Cancer Care Alliance (@OCCA_Cancer)Photo by Optimal Cancer Care Alliance (@OCCA_Cancer)Photo by Optimal Cancer Care Alliance (@OCCA_Cancer)Photo by Optimal Cancer Care Alliance (@OCCA_Cancer)
And here's the white paper for the conference! friendsofcancerresearch.org/…
1
Optimal Cancer Care Alliance retweeted
Today at 10:00 PM CEST, Dr. Fabio Turco will present the EORTC 2238 “#DeEscalate” #PragmaticTrial at the 3rd Optimal Cancer Care Alliance Virtual Meeting. 👉optimalcancercare.org/ @OCCA_Cancer @UChicago #CancerResearch #ClinicalTrials #Oncology
1
1
4
525
Optimal Cancer Care Alliance retweeted
Today at 10:35 PM CEST, Our CEO, Dr. Denis Lacombe, will discuss the EMA #CancerMedicinesForum at the 3rd Optimal Cancer Care Alliance Virtual Meeting. 👉optimalcancercare.org/ @OCCA_Cancer @UChicago #CancerResearch #ClinicalTrials #Oncology
2
2
668
Optimal Cancer Care Alliance retweeted
This is going to be excellent meeting . All are encouraged to register and attend . @OCCA_Cancer
3
1
4
718
Optimal Cancer Care Alliance retweeted
Important meeting announcement. Optimal dosing of Anticancer drugs . @OCCA_Cancer @ian_tannock @tmhmedoncalumni @ISMPOofficial @IJMPOofficial
1
3
9
886
Optimal Cancer Care Alliance retweeted
Efforts to stop ✋ Merc from applying for patent extension for SUBCUT pembrolizumab. Letter by USA 🇺🇸 senetors and congress members @SenWarren @BernieSanders @RepKatiePorter @RepJayapal . Such efforts 👌👏 will hopefully help to get more access to pembrolizumab across the 🌎
1
8
1
18
1,949
Optimal Cancer Care Alliance retweeted
This article summarises ongoing immune checkpoint inhibitor optimisation trials. Establishing optimised immune checkpoint inhibitor protocols will be challenging, but is a necessary step toward global access. @OCCA_Cancer @MRCCTU nature.com/articles/s41591-0…
3
7
Optimal Cancer Care Alliance retweeted
Please join us in reading out latest publication in @NatureMedicine, discussing dose optimization for ICI to allow global access. Thank you to all the co-authors for their guidance: Dr. Gilbert, @MarcusButler_PM, @drdgoldstein and Dr. Tannock nature.com/articles/s41591-0…
5
13
4
52
Optimal Cancer Care Alliance retweeted
.@OCCA_Cancer: "It is highly likely that CodeBreak 201 will show that the therapeutic index of sotorasib 240mg daily is superior to that of sotorasib 960 mg daily. Given this probable result, we suggest that the FDA should not grant full approval." cancerletter.com/guest-edito…
Optimal Cancer Care Alliance retweeted
Interventional Pharmacoeconomics . Excellent points made by @ian_tannock @SirohiBhawna @oncology_bg #choosingwisely22 @ecancer @OCCA_Cancer
1
10
1
16
Optimal Cancer Care Alliance retweeted
Happy to present the REFINE trial testing Reducing the Frequency of Immune Checkpoint Inhibition across different cancers @myESMO. There is the potential to improve QoL and reduce toxicity for patients. The #RCC cohort is currently recruiting. @MRCCTU #ESMO2022
5
3
3
42
For those at #ESMO22 Paris - Please join us Friday 9 Sept from 18:30-21:30 for the @OCCA_Cancer / @MRCCTU Optimising Cancer Care Update. A great evening of talks, discussion, and buffet in store. 1/2
1
2
1
4
For registration or for more details, please DM @OCCA_Cancer or @drdgoldstein 2/2
1
More @OCCA_Cancer action on Capitol Hill - from @US_FDA Appropriations Bill for 2023… 1/
1
2
“The Committee strongly encourages FDA to organize clinical trials…of marketed cancer drugs and biologics to assess whether dosing and frequency adjustments may decrease the cost of care and/or toxicities of treatment without compromising efficacy.” 4/
1
1
2
Lots of research and advocacy on behalf of patients in the US by @OCCA_Cancer, @FDAOncology, and @CancerResrch has gotten us here. Making this vision a reality will require continued efforts globally! We’re excited to get to work. 5/
2